The research team, led by Yogesh Bhaskar Singh Tanwer, Suman Sourabh, and Sabyasachi Bhunia of the Central University of Jharkhand, together with Sanchari Pal and Debjit Das of Triveni Devi Bhalotia College, combined three simple ingredients in a single flask: a substituted salicylaldehyde, either 4-hydroxycoumarin or 1,3-dimethylbarbituric acid, and an electron-rich arene such as 1,3,5-trimethoxybenzene. Heating this mixture at 90 degrees Celsius in a mixture of lemon juice and ethanol produced the desired fused chromene products in yields ranging from 74 to 87 percent for the chromeno[4,3-b]chromene series and good to excellent yields for the chromeno[2,3-d]pyrimidine analogues. No metals, no exotic reagents, no chromatographic purification—just filtration and a wash with aqueous ethanol in most cases.

The appeal of multicomponent reactions lies in their efficiency. Rather than assembling a target molecule step by step, isolating and purifying intermediates at each stage, a multicomponent reaction stitches three or more building blocks together in one operation. This convergence saves time, energy, solvent, and manpower, which is why such reactions are prized in pharmaceutical and combinatorial chemistry. But traditional versions of these reactions often rely on volatile organic solvents and toxic or costly metal catalysts, undermining their green credentials. The Indian team’s approach sidesteps both problems by using a food-derived catalyst in a largely benign medium.

Lemon juice has been attracting growing attention as a biocatalyst in recent years. It is cheap, widely available, water-soluble, biodegradable, and non-toxic, and its natural acidity—derived primarily from citric acid—allows it to substitute for harmful metallic and non-metallic acid catalysts in a range of organic transformations. In the new study, the researchers found that lemon juice alone in water failed to deliver any product even after 24 hours of reflux, largely because the organic starting materials dissolve poorly in the aqueous juice. Adding ethanol as a co-solvent solved the solubility problem dramatically: with 2.0 milliliters of lemon juice and 1.5 milliliters of ethanol at 90 degrees Celsius, the model reaction between salicylaldehyde, 1,3,5-trimethoxybenzene, and 4-hydroxycoumarin delivered the product 4a in 89 percent yield.

With the optimized conditions in hand, the team explored how broadly the method could be applied. A variety of salicylaldehyde derivatives reacted smoothly with 1,3,5-trimethoxybenzene and 4-hydroxycoumarin, furnishing nine different chromeno[4,3-b]chromene products in 74 to 87 percent yields. Switching the coumarin component for 1,3-dimethylbarbituric acid redirected the chemistry toward chromeno[2,3-d]pyrimidines, seven derivatives of which were obtained in good to excellent yields. The researchers also demonstrated that dibenzylaniline, another strongly electron-rich arene, could serve as the arene component, giving the corresponding products in good yields, including a chromeno[2,3-d]pyrimidine in 78 percent yield.

The substrate scope does have a clear boundary. The reaction tolerates a range of substituents on the salicylaldehyde ring, but it works only with strongly electron-rich arenes. Weaker candidates such as mesitylene, dimethoxybenzene, and methoxynaphthalene showed little to no activity, a limitation that reflects the electrophilic character of the key intermediate in the reaction pathway. Even so, the products obtained represent a class of compounds that had not previously been accessible through a general protocol using direct arene functionalization at the 7 and 5 positions, making the method a genuine addition to the synthetic toolbox.

To understand how the reaction actually works, the team ran a series of control experiments. When salicylaldehyde and 1,3,5-trimethoxybenzene were heated together without the coumarin component, no adduct formed, ruling out a direct coupling pathway. When salicylaldehyde and 4-hydroxycoumarin were combined under the optimized conditions, a condensed product—labeled intermediate B—formed in 66 percent yield within six hours. The researchers isolated this intermediate, confirmed its structure by nuclear magnetic resonance spectroscopy, and then showed that reacting it with 1,3,5-trimethoxybenzene gave the final chromeno[4,3-b]chromene in 91 percent yield. This established that the three-component reaction proceeds through intermediate B rather than through a different sequence.

Based on these observations, the authors proposed a plausible mechanism. The acidity of the lemon juice first promotes a Knoevenagel condensation between the salicylaldehyde and the 4-hydroxycoumarin, generating the electron-poor Michael acceptor B. The electron-rich arene then adds to this acceptor in a Michael-type addition, producing an intermediate containing a tertiary carbon center. Finally, an acid-driven intramolecular ring closure followed by dehydration delivers the fused chromene product. In other words, the citric acid in the juice orchestrates every key step of the cascade, from initial condensation to final cyclization, without any metal assistance.

Practical considerations further strengthen the case for the method. The structures of two representative products were unambiguously confirmed by single-crystal X-ray crystallographic analysis, and all compounds were characterized by proton and carbon NMR spectroscopy, high-resolution mass spectrometry, and elemental analysis. Crucially, the team demonstrated that the reaction can be scaled up: a 10-millimole-scale run of the model compound proceeded with effectiveness and yields comparable to the small-scale experiments, suggesting genuine potential for commercial and industrial application. Because nearly all products precipitate from the reaction mixture, purification requires only filtration and washing, eliminating extraction steps, column chromatography, and the large volumes of harmful organic solvents they consume.

The significance of the work extends beyond the specific molecules made. Chromene derivatives are distributed widely in natural products, drugs, and edible plants, and their fused hybrids with coumarin or barbituric acid units display a striking range of pharmacological activities, including antitumor, anti-inflammatory, cytotoxic, antioxidant, antithrombotic, and antiplatelet effects, along with useful photophysical properties. A hybrid framework combining chromene with other bioactive analogues may incorporate the characteristics of both and enhance biological activity, which is precisely why synthetic chemists keep seeking better ways to build them. By replacing toxic metals and hazardous solvents with a kitchen staple, the Indian team has shown that the principles of green chemistry—waste prevention, safer solvents, catalysis, and energy efficiency—can be honored without sacrificing yield, scope, or scalability. The study was funded by the Science and Engineering Research Board and the University Grants Commission of India, and it stands as a vivid reminder that sometimes the most sustainable catalyst is sitting in the refrigerator.

Subject of Research: Lemon juice-mediated green synthesis of chromeno[4,3-b]chromene and chromeno[2,3-d]pyrimidine derivatives via one-pot three-component reactions

Article Title: Lemon juice mediated environmentally benign synthesis of functionalized chromeno[4,3-b]chromene/chromeno[2,3‐d]pyrimidine derivatives via one-pot three component reaction

Article References: Lemon juice mediated environmentally benign synthesis of functionalized chromeno[4,3-b]chromene/chromeno[2,3‐d]pyrimidine derivatives via one-pot three component reaction. (n.d.). https://doi.org/10.1007/s44509-026-00001-7

Image Credits: AI Generated

DOI: 10.1007/s44509-026-00001-7

Keywords: lemon juice, green chemistry, multicomponent reaction, chromene, chromenopyrimidine, organocatalysis, salicylaldehyde, 4-hydroxycoumarin, barbituric acid, Knoevenagel condensation, sustainable synthesis, metal-free catalysis

Polyhydroquinolines are not laboratory curiosities. These nitrogen-containing ring systems, close cousins of the dihydropyridine scaffolds found in calcium-channel blockers, have been linked to an impressive range of pharmacological activities, including hepatoprotective, antidiabetic, geroprotective, bronchodilator, vasodilator, antiatherosclerotic and antitumor effects. Related structures have also shown antiplasmodial, antibacterial and antimalarial activity. Because of this versatility, medicinal chemists have spent decades searching for efficient ways to assemble them, and the classic route traces all the way back to 1882, when Arthur Hantzsch first described a one-pot condensation of an aldehyde, a beta-ketoester and ammonia in acetic acid or ethanol.

The Hantzsch reaction is a prime example of a multicomponent reaction, a strategy in which three or more starting materials combine in a single step to form a product that incorporates most of the atoms of the reactants. Multicomponent reactions are prized for their atom economy and for slashing the number of synthetic steps required to reach complex heterocyclic scaffolds. Yet many modern versions of the polyhydroquinoline synthesis still carry baggage: metal salts that complicate separation, ionic liquids that are costly, catalysts that cannot be reused, or solvents that generate waste. The new study set out to strip away as much of that baggage as possible.

The researchers’ catalyst of choice, PFPAT, is a non-metallic organoammonium salt whose design is deceptively simple but chemically clever. The strongly electron-withdrawing pentafluorophenyl group, paired with a weakly coordinating triflate anion, makes the ammonium proton unusually acidic. That acidity allows PFPAT to activate carbonyl compounds through proton transfer and hydrogen-bonding interactions, the key first move in the multicomponent condensation. Because the catalyst is a metal-free organic salt, it avoids many of the separation and recyclability problems that plague soluble metal catalysts, particularly when reactions are scaled up.

The model reaction combined benzaldehyde, ethyl acetoacetate, dimedone and ammonium acetate, with reaction progress tracked by thin-layer chromatography. Without any catalyst, the mixture yielded only trace product even after prolonged reaction, and heating to 90 degrees Celsius alone brought only marginal improvement, a clear sign that thermal activation is not enough. When PFPAT was introduced, the picture changed dramatically. Raising the catalyst loading from 2.5 to 10 mole percent steadily improved both yield and reaction time, and 10 mole percent at 90 degrees Celsius emerged as the optimum. Pushing the loading further, to 12.5 or 15 mole percent, offered no meaningful benefit, indicating that the active catalytic sites were already sufficient for efficient conversion.

Solvent screening reinforced the green credentials of the protocol. The team tested acetonitrile, chloroform, dimethyl sulfoxide and dichloromethane, and even the best performer, DMSO, managed only a moderate 68 percent yield with longer reaction times. Nothing matched the solvent-free system. Under the optimized conditions, the model product was isolated in 86 percent yield in just three hours, with the crude solid obtained by simple filtration, washed with a minimal volume of ethyl acetate and petroleum ether, and purified by recrystallization from hot aqueous ethanol. The work-up is deliberately mundane, which is precisely the point for a procedure intended to be practical.

To benchmark PFPAT against the competition, the researchers ran the same model reaction with a lineup of commercially available Lewis and Brønsted acid catalysts under identical conditions. Metal salts such as zinc chloride, iron(III) chloride and iron(III) iodide delivered conversions of only 60 to 72 percent with isolated yields of 38 to 50 percent. The lanthanide triflate La(OTf)3 fared better at 85 percent conversion and 65 percent yield, while p-toluenesulfonic acid and heterogeneous titanium dioxide pushed past 90 percent conversion with yields above 70 percent over five hours. PFPAT outperformed them all, achieving complete conversion and an 86 percent yield in three hours. Calculated turnover numbers told the same story: PFPAT posted the highest TON of 8.6 and TOF of 2.87 per hour among the catalysts tested, reflecting its strong Brønsted acidity and its knack for accelerating the cyclocondensation under mild, solvent-free conditions.

The substrate scope revealed a clear and chemically satisfying pattern. Eleven substituted benzaldehydes were converted into their polyhydroquinoline products, spanning electron-donating groups such as methyl, methoxy and hydroxy as well as electron-withdrawing halogens and nitro groups. Electron-poor aldehydes reacted fastest and best: 4-nitrobenzaldehyde gave its product in 94 percent yield within just 1.5 hours, while electron-rich 4-methoxybenzaldehyde needed four hours and delivered 78 percent. The explanation lies in the first step of the mechanism, a Knoevenagel condensation in which the aldehyde carbonyl must be attacked. Electron-withdrawing substituents make the carbonyl carbon more electrophilic, speeding both the condensation and the subsequent cyclization, whereas electron-donating groups dampen electrophilicity and slow the cascade. The consistent trend across substrates suggests the catalytic system has a general affinity for electron-deficient aromatic aldehydes, a useful guide for anyone planning to apply the method.

Mechanistically, the reaction unfolds as a classic Hantzsch-type sequence. PFPAT first activates the aldehyde carbonyl through hydrogen bonding and acid interactions, priming it for nucleophilic attack. Ammonium acetate then reacts with ethyl acetoacetate to generate an enamine intermediate, while dimedone undergoes a PFPAT-catalyzed Knoevenagel condensation with the activated aldehyde to form a reactive alpha,beta-unsaturated intermediate. The enamine adds to this activated olefin in a Michael-type addition, followed by intramolecular cyclization and tautomerization to close the polyhydroquinoline ring. The catalyst’s ability to promote proton transfers and stabilize charged intermediates through each of these stages is what allows the whole cascade to proceed smoothly without solvent.

Recyclability, often the Achilles heel of homogeneous catalysts, proved to be a genuine strength here. After each run, PFPAT was recovered simply by extraction with ethyl acetate, dried under vacuum and reused without any further treatment. The catalyst retained its activity effectively through four consecutive cycles, with only a slight loss attributable to partial solubility in the aqueous phase. On the fifth cycle, performance dropped more sharply, with product yield falling to 70 percent and catalyst recovery to 63 percent, but the overall pattern still marks PFPAT as a viable, eco-friendly option for repeated use. Combined with yields of 72 to 94 percent across the substrate range, short reaction times, operational simplicity and the complete elimination of reaction solvents, the protocol offers a template for sustainable heterocyclic synthesis. The authors suggest that future work could expand the substrate scope, probe the biological activities of the products, and evaluate whether the process can be scaled for industrial application, a prospect that would bring a 140-year-old reaction firmly into the era of green chemistry.

Subject of Research: Green solvent-free Brønsted acid-catalyzed synthesis of polyhydroquinoline derivatives via Hantzsch multicomponent reaction

Article Title: An optimized and sustainable Brønsted acid-catalyzed green synthesis of polyhydroquinoline derivatives

Article References: Pande, P., Niralwad, K., & Patki, A. (2026). An optimized and sustainable Brønsted acid-catalyzed green synthesis of polyhydroquinoline derivatives. Discover Chemistry, 3(1), Article 551. https://doi.org/10.1007/s44371-026-00996-9

Image Credits: AI Generated

DOI: 10.1007/s44371-026-00996-9

Keywords: polyhydroquinolines, PFPAT, green chemistry, Hantzsch reaction, Brønsted acid catalysis, multicomponent reactions, solvent-free synthesis, catalyst recyclability, heterocyclic chemistry, drug discovery, Knoevenagel condensation, sustainable synthesis